Bally's Corp
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-09-30; filed 2024-11-08.
0001747079-24-000098
ITEM 1A. Risk FactorsCurrent report: 10-Q
Period ended 2025-03-31; filed 2025-05-12.
0001747079-25-000088
ITEM 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 2 previous paragraphs and 5 current paragraphs.
2 unchanged; 0 reworded; 3 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to our risk factors contained in Part I. Item IA. “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2024.
Added paragraphs (3)
Current report
The following table provides information about share repurchases made by the Company of its common stock during the quarter ended March 31, 2025 (in thousands, except average price paid per share):
Current report
(a) On February 7, 2025, the Company completed the Merger and paid cash consideration of $18.25 per share to holders of 22.9 million of the Company’s outstanding shares.
Current report
(b) As of March 31, 2025, there was $95.5 million available for use under the Company’s capital return program, subject to limitations in its regulatory and debt agreements. See Note 17 “Stockholders’ Equity” included in Part I. Item 1 of this Quarterly Report on Form 10-Q for a description of the capital return program